rs145203578

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_001128840.3(CACNA1D):​c.1344C>T​(p.Ile448Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00134 in 1,614,168 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0011 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0014 ( 3 hom. )

Consequence

CACNA1D
NM_001128840.3 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.447

Publications

1 publications found
Variant links:
Genes affected
CACNA1D (HGNC:1391): (calcium voltage-gated channel subunit alpha1 D) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, namely alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1D subunit. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
CACNA1D Gene-Disease associations (from GenCC):
  • aldosterone-producing adenoma with seizures and neurological abnormalities
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Illumina, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • sinoatrial node dysfunction and deafness
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.044).
BP6
Variant 3-53702764-C-T is Benign according to our data. Variant chr3-53702764-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 504765.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.447 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00108 (165/152284) while in subpopulation NFE AF = 0.00181 (123/68012). AF 95% confidence interval is 0.00155. There are 0 homozygotes in GnomAd4. There are 78 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001128840.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1D
NM_000720.4
MANE Plus Clinical
c.1344C>Tp.Ile448Ile
synonymous
Exon 9 of 49NP_000711.1Q01668-2
CACNA1D
NM_001128840.3
MANE Select
c.1344C>Tp.Ile448Ile
synonymous
Exon 9 of 48NP_001122312.1Q01668-1
CACNA1D
NM_001128839.3
c.1344C>Tp.Ile448Ile
synonymous
Exon 9 of 46NP_001122311.1Q01668-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1D
ENST00000288139.11
TSL:1 MANE Plus Clinical
c.1344C>Tp.Ile448Ile
synonymous
Exon 9 of 49ENSP00000288139.3Q01668-2
CACNA1D
ENST00000350061.11
TSL:1 MANE Select
c.1344C>Tp.Ile448Ile
synonymous
Exon 9 of 48ENSP00000288133.5Q01668-1
CACNA1D
ENST00000481478.2
TSL:1
c.1344C>Tp.Ile448Ile
synonymous
Exon 9 of 49ENSP00000418014.2H0Y879

Frequencies

GnomAD3 genomes
AF:
0.00108
AC:
165
AN:
152166
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00181
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00106
AC:
267
AN:
251454
AF XY:
0.00115
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.00113
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000231
Gnomad NFE exome
AF:
0.00174
Gnomad OTH exome
AF:
0.00179
GnomAD4 exome
AF:
0.00137
AC:
1997
AN:
1461884
Hom.:
3
Cov.:
32
AF XY:
0.00135
AC XY:
982
AN XY:
727240
show subpopulations
African (AFR)
AF:
0.000269
AC:
9
AN:
33478
American (AMR)
AF:
0.00134
AC:
60
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39700
South Asian (SAS)
AF:
0.000499
AC:
43
AN:
86256
European-Finnish (FIN)
AF:
0.000318
AC:
17
AN:
53420
Middle Eastern (MID)
AF:
0.00382
AC:
22
AN:
5764
European-Non Finnish (NFE)
AF:
0.00155
AC:
1723
AN:
1112012
Other (OTH)
AF:
0.00197
AC:
119
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
112
224
337
449
561
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00108
AC:
165
AN:
152284
Hom.:
0
Cov.:
33
AF XY:
0.00105
AC XY:
78
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.000361
AC:
15
AN:
41552
American (AMR)
AF:
0.00131
AC:
20
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00181
AC:
123
AN:
68012
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
8
17
25
34
42
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00139
Hom.:
0
Bravo
AF:
0.00107
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00196
EpiControl
AF:
0.00130

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not provided (5)
-
-
3
not specified (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
4.0
DANN
Benign
0.55
PhyloP100
-0.45
PromoterAI
-0.047
Neutral
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145203578; hg19: chr3-53736791; COSMIC: COSV55454221; COSMIC: COSV55454221; API